Department of Urology, IRCCS "Regina Elena" National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Department of Urology, "Sapienza" University, Rome, Italy.
World J Urol. 2021 Jun;39(6):2005-2010. doi: 10.1007/s00345-020-03391-w. Epub 2020 Jul 29.
Robotic-assisted simple prostatectomy (RASP) is an established surgical procedure for the management of obstructive symptoms caused by large adenomas. Traditionally, this is performed according to the trans-vescical (Freyer) or trans-capsular (Millin) technique. We recently described a novel urethra-sparing (Madigan) robotic technique which showed promising preliminary results. In this study, we compared the above techniques for perioperative and 1-year patient-reported outcomes.
We retrospectively collected data from patients who underwent RASP across the three techniques, performed by two experienced surgeons in our center. We assessed patient self-reported pre-operative and post-operative functional outcomes with validated questionnaires: IPSS, IIEF short form, ICIQ short form, MSHQ Short Form. Continuous and categorical variables were compared between groups using the Mood's median test and the Chi-square tests, respectively.
Millin, Madigan and Freyer procedures were performed in 23 (51%), 14 (31%) and 8 (18%) cases, respectively. No significant differences were observed for baseline ASA score, BMI, prostate volume, IPSS, IIEF, ICIQ and MSHQ scores (all p ≥ 0.2), as well as post-operative obstructive symptoms relief (IPSS: p = 0.25), continence (ICIQ: p = 0.54), complication rates (p = 0.32) and hospital stay (p = 0.23). Operative time was longer for Madigan procedures (p = 0.05). The 1-year MSHQ and IIEF scores were significantly higher in the Madigan cohort (p = 0.008 and p = 0.04, respectively).
RASP proved to be a safe surgical approach, providing an effective and durable relief of obstructive symptoms at mid-term follow-up regardless of the technique used. The Madigan technique provided significant benefits in terms of self-assessed quality of sexual function.
机器人辅助简单前列腺切除术(RASP)是一种成熟的手术方法,可用于治疗由大腺瘤引起的梗阻症状。传统上,该手术采用经膀胱(Freyer)或经囊(Millin)技术进行。我们最近描述了一种新的尿道保留(Madigan)机器人技术,该技术显示出有前景的初步结果。在这项研究中,我们比较了上述三种技术的围手术期和 1 年患者报告的结果。
我们回顾性地收集了在我们中心由两位经验丰富的外科医生采用三种技术进行 RASP 的患者数据。我们使用经过验证的问卷评估患者术前和术后的功能结果:国际前列腺症状评分(IPSS)、国际勃起功能指数(IIEF)简短形式、国际尿控协会症状问卷(ICIQ)简短形式、男性性功能健康问卷(MSHQ)简短形式。使用Mood 的中位数检验和卡方检验分别比较组间的连续和分类变量。
Millin、Madigan 和 Freyer 手术分别在 23 例(51%)、14 例(31%)和 8 例(18%)患者中进行。基线 ASA 评分、BMI、前列腺体积、IPSS、IIEF、ICIQ 和 MSHQ 评分(均 p≥0.2)以及术后梗阻症状缓解(IPSS:p=0.25)、控尿(ICIQ:p=0.54)、并发症发生率(p=0.32)和住院时间(p=0.23)无显著差异。Madigan 手术的手术时间较长(p=0.05)。Madigan 组的 1 年 MSHQ 和 IIEF 评分显著更高(p=0.008 和 p=0.04)。
RASP 是一种安全的手术方法,无论采用何种技术,从中期随访来看,均可有效且持久地缓解梗阻症状。Madigan 技术在自我评估的性功能质量方面具有显著优势。